---
title: "Spero Therap (SPRO.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/SPRO.US/norm.md"
symbol: "SPRO.US"
name: "Spero Therap"
parent: "https://longbridge.com/zh-HK/quote/SPRO.US.md"
datetime: "2026-06-19T13:12:42.599Z"
locales:
  - [en](https://longbridge.com/en/quote/SPRO.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SPRO.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SPRO.US/norm.md)
---

# Spero Therap (SPRO.US) — 財務報表

## 損益表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.1257 | 0.5357 | -0.1312 | -0.0303 | -0.2504 |
| ROE | -51.47% | 294.87% | -99.55% | -20.41% | -138.77% |
| 營業收入 | 258000.00 | 41.30M | 5.44M | 14.19M | 5.87M |
| 凈利潤 | -7.20M | 31.52M | -7.38M | -1.70M | -13.87M |
| 營業利潤 | -7.54M | 31.41M | -7.33M | -2.36M | -14.56M |
| 毛利率 | -1027.52% | 86.46% | -57.98% | 24.79% | -131.63% |
| 凈利率 | -2791.86% | 76.33% | -135.65% | -11.98% | -236.06% |
| 利潤含金量 | -47.52% | -376.06% | -42.07% | - | - |

## 資產負債表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 59.02M | 68.92M | 54.17M | 62.12M | 77.71M |
| 權益乘數 | 1.11 | 1.17 | 2.04 | 1.89 | 2.30 |
| 每股凈資產 | 0.9144 | 1.05 | 0.4705 | 0.5843 | 0.6049 |
| 資產周轉率 | 0.8950 | 0.7445 | 0.4283 | 0.4583 | 0.3633 |
| 現金及短投 | 56.13M | 40.27M | 48.62M | 31.19M | 48.89M |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | 1.26M | 1.48M | 1.69M | 2.56M | 2.84M |
| 凈債務 | -53.66M | -37.37M | -45.27M | -27.58M | -44.93M |

## 現金流量表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | 15.86M | -8.35M | 17.42M | -17.69M | -4.00M |
| 投資現金流 | - | - | - | - | - |
| 融資現金流 | - | - | - | - | - |
| 自由現金流 | 18.55M | -7.52M | 19.62M | -17.40M | 1.05M |
| 現金流充裕率 | - | - | - | - | - |
| 舉債與償債 | - | - | - | - | - |
| 資本支出 | - | - | - | - | - |